Placental Growth Factors Market

Placental Growth Factors Market Outlook (2023 to 2033)

The placental growth factors market size is projected to be worth USD 34.9 million in 2023. The market is likely to surpass USD 64.6 million by 2033 at a CAGR of 6.3% during the forecast period.

The market for therapeutic interventions and diagnostic procedures linked to placental growth factors is referred to as the placental growth factors market. Proteins called placental growth factors are essential for the placenta's growth and operation during pregnancy.

They are released by the placenta and serve a number of purposes, such as encouraging angiogenesis (the creation of new blood vessels) and controlling the proliferation and differentiation of placental cells.

Other Drivers Propelling the Demand for Placental Growth Factors include:

• The rising prevalence of pregnancy-related disorders such as preeclampsia, gestational diabetes, intrauterine growth restriction (IUGR), and placental insufficiency has led to a growing need for effective diagnostic tools and therapeutic interventions.
• Early detection and risk assessment are becoming increasingly important in prenatal treatment. To determine the likelihood of experiencing pregnancy problems, placental growth factors including placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) are used as biomarkers.
• Growing awareness among healthcare professionals, patients, and advocacy groups about the importance of placental health and its impact on pregnancy outcomes is driving the demand for placental growth factors.

Challenges for Companies /Manufacturers in the Placental Growth Factors Market:

• Despite advancements in research, the understanding of placental biology and the precise mechanisms of placental growth factors is still evolving. The complex nature of placental development and function poses challenges in accurately interpreting the role and significance of different placental growth factors.
• There may be a lack of standardization in the assays and techniques used to assess placental growth factors. The consistency and comparability of results may be impacted by the variation in assay techniques, reference intervals, and interpretation criteria.
• Some diagnostic procedures for determining placental growth factors can be expensive, which restricts their availability in some medical settings or areas with little resources. The cost and accessibility of these tests can be problematic, especially in low-resource areas where access to cutting-edge diagnostic technology may be constrained.

Opportunities in the Placental Growth Factors Industry:

• The market for placental growth factors has prospects due to the rising emphasis on personalized treatment. Prenatal treatment and therapies can be tailored depending on a woman's unique placental health to enhance pregnancy outcomes and lower the risk of problems.
• The treatment of illnesses connected to pregnancy can benefit from placental growth factors. To restore placental function and avoid or treat difficulties, there is a chance to create tailored medicines that alter the expression or activity of placental growth factors.

Latest Trends in the Placental Growth Factors Market:

• The trend towards point-of-care testing is impacting the placental growth factors market. Point-of-care testing allows for rapid and convenient measurement of placental growth factors, enabling real-time assessment and immediate decision-making.
• Collaborative research initiatives and consortia are emerging to accelerate placental research and advance the understanding of placental growth factors. These collaborative efforts bring together researchers, clinicians, and industry stakeholders to share data, standardize protocols, conduct large-scale studies, and develop consensus guidelines.
• The market for placental growth factors is being impacted by the trend towards patient-centered care. Patients are increasingly being included in decision-making, receiving individualized information, and having their unique needs and preferences met.

Attributes	Details
Placental Growth Factors Market Size (2023)	USD 34.9 million
Placental Growth Factors Market Projected Size (2033)	USD 64.6 million
Value CAGR (2023 to 2033)	6.3%

2017 to 2022 Placental Growth Factors Demand Outlook Compared to 2023 to 2033 Forecast

From 2017 to 2022, the global placental growth factors market experienced a CAGR of 3.9%, reaching a market size of USD 34.9 million in 2023.

From 2017 to 2022, the historic outlook of the placental growth factors market also includes the adoption and integration of these tests into routine prenatal care practices.

Healthcare providers have increasingly recognized the clinical utility of placental growth factor testing in risk assessment, early detection, and monitoring of pregnancy-related complications. As a result, the market has witnessed increased utilization of these tests in both high-risk and routine prenatal care setting

Future Forecast for Placental Growth Factors Industry:

Looking ahead, the global placental growth factors industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 64.6 million by 2033. There is a growing recognition of the importance of placental health in ensuring optimal maternal and fetal outcomes.

This increased awareness is expected to drive the demand for placental growth factor testing and related products. Continuous advancements in diagnostic technologies, including improved assays, point-of-care testing devices, and non-invasive imaging techniques, are expected to enhance the accuracy, convenience, and accessibility of placental growth factor assessments. These advancements are likely to contribute to market growth.

Country-Wise Insights

Placental Growth Factors Market to Surge in the United States Due Increasing Incidence of Pregnancy-related Complications.

Country	The United States
Market Size (USD million) by End of Forecast Period (2033)	USD 24.1 million
CAGR % 2023 to End of Forecast (2033)	6.0%

The placental growth factors industry in the United States is expected to reach a market size of USD 24.1 million by 2033, expanding at a CAGR of 6.0%. The United States has seen a rise in pregnancy-related complications such as preeclampsia, gestational diabetes, and intrauterine growth restriction.

Placental growth factors play a crucial role in assessing and managing these complications, leading to an increased demand for placental growth factor testing and related products.

Supportive Healthcare Infrastructure for Placental Growth Factors by Healthcare Professional to Propel the United Kingdom Market Growth

Country	The United Kingdom
Market Size (USD million) by End of Forecast Period (2033)	USD 2.8 million
CAGR % 2023 to End of Forecast (2033)	5.7%

The placental growth factors industry in the United Kingdom is expected to reach a market size of USD 2.8 million, expanding at a CAGR of 5.7% during the forecast period. The UK has a well-developed healthcare infrastructure that supports the growth of the placental growth factors market.

The presence of specialized healthcare facilities, research institutions, and academic centers facilitates the development, validation, and adoption of placental growth factor-based diagnostic tests and therapeutic interventions. The supportive healthcare infrastructure contributes to market growth by fostering research, innovation, and market access.

Notable Growth Expected in China's Placental Growth Factors Market Due to Growing Adoption of Assisted Reproductive Technologies (ART)

Country	China
Market Size (USD million) by End of Forecast Period (2033)	USD 5.6 million
CAGR % 2023 to End of Forecast (2033)	7.0%

The placental growth factors industry in China is anticipated to reach a market size of USD 5.6 million, moving at a CAGR of 7.0% during the forecast period. The use of assisted reproductive technologies, such as in vitro fertilization (IVF), is increasing in China.

These technologies often involve monitoring and optimizing the health of the placenta for successful outcomes. Placental growth factors are valuable tools in assessing placental health and optimizing fertility treatments. The growing adoption of ART procedures drives the demand for placental growth factors in the Chinese market.

Increasing Focus on Maternal and Fetal Health to Drive Market Growth in Japan

Country	Japan
Market Size (USD million) by End of Forecast Period (2033)	USD 2.4 million
CAGR % 2023 to End of Forecast (2033)	5.2%

The placental growth factors industry in Japan is estimated to reach a market size of USD 2.4 million by 2033, thriving at a CAGR of 5.2%. Japan places a strong emphasis on maternal and fetal health, with a high level of awareness and importance given to prenatal care.

Placental growth factors are crucial biomarkers for assessing placental health and identifying potential complications. The increasing focus on maternal and fetal health drives the demand for placental growth factor testing and related products.

Demand for Placental Growth Factors is Rising Due to Collaboration and Partnership to Fuel Market Growth in South Korea

Country	South Korea
Market Size (USD million) by End of Forecast Period (2033)	USD 1.0 million
CAGR % 2023 to End of Forecast (2033)	6.7%

The placental growth factors industry in South Korea is expected to reach a market size of USD 1.0 million, expanding at a CAGR of 6.7% during the forecast period. Collaborative efforts between healthcare institutions, research organizations, and industry stakeholders play a significant role in driving innovation and market growth.

Partnerships between academia and industry support research and development activities, clinical trials, and the commercialization of placental growth factor-based products. Collaborations and partnerships contribute to the growth of the placental growth factors market in South Korea.

Category-Wise Insights

Ophthalmology to Dominate Placental Growth Factors Industry through 2033

The ophthalmology dominated the placental growth factors industry with value share of 57.0% in 2022. Ophthalmic conditions such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion can lead to the development of abnormal blood vessels in the retina, a process known as ocular neovascularization.

Placental Growth Factors, including vascular endothelial growth factor (VEGF), are involved in the formation of these abnormal blood vessels. Ophthalmologists use anti-VEGF therapies, which may include PGF-based drugs, to inhibit the growth of these vessels and manage ocular neovascularization. The demand for PGF-based drugs in ophthalmology contributes to the growth of the Placental Growth Factors market.

Which End User is Widely Adopted the Placental Growth Factors?

The pharmaceutical and biotechnology companies segment dominated the placental growth factors industry with value share of 51.2% in 2022. Pharmaceutical and biotechnology companies are involved in the discovery and formulation of PGF-based drugs.

They utilize their expertise in molecular biology, pharmacology, and drug formulation to design and develop drugs that can modulate the activity of PGF and its receptors. These companies explore various approaches, including small molecules, antibodies, gene therapies, and sustained-release formulations, to optimize the delivery and therapeutic potential of PGF-based drugs. Their efforts in drug discovery and formulation contribute to the availability of diverse PGF-based therapies in the market.

How Key Players Stay Competitive in the Placental Growth Factors Industry?

The placental growth factors sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.

Key Strategies Used by the Participants

Product Development

To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.

Strategic Alliances & Collaborations

Strategic alliances and partnerships with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.

Expansion into Emerging Markets

The placental growth factors sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.

Acquisitions and mergers

Mergers and acquisitions are frequently used by key players in the placental growth factors business to consolidate their market position, extend their product range, and gain access to new markets.

Key Players in the Placental Growth Factors Industry

• Alteogen Inc.
• Chengdu Kanghong Pharmaceuticals Group Co Ltd
• Clearside BioMedical, Inc.
• Formycon AG
• Regeneron Pharmaceuticals Inc
• ThromboGenics NV
• Luye Pharma Group Ltd
• Alvotech SA
• Amgen Inc
• Celltrion Inc
• Cinnagen Co
• GlycoNex Inc

Key Developments in the Placental Growth Factors Market:

In March 2023, The suprachoroidal space (SCS®) is being revolutionised by Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical firm. Its results for the fourth quarter and year ending December 31, 2022, were released along with a corporate update.

Segmentation Analysis of the Placental Growth Factors Market

By Therapy Areas:

• Ophthalmology
• Metabolic Disorder
• Oncology
• Others

By End User:

• Pharmaceutical and Biotechnology Companies
• Research Centers & Academic Institutes
• CMO and CDMO

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

Frequently Asked Questions

What is the Placental Growth Factors Market

The market is valued at USD 34.9 million in 2023. 

Who are the Key Placental Growth Factors Market Players? 

Alteogen Inc., Clearside BioMedical, Inc., and Formycon AG are the key market players. 

What is the Growth Forecast for the Placental Growth Factors Market? 

The market is forecast to register a CAGR of 6.3% through 2033. 

How was the Historical Performance of the Market? 

The market registered a CAGR of 3.9% from 2017 to 2022.

Which is the Top Trend in the Placental Growth Factors Market? 

Early detection of pregnancy-related complications is encouraging market growth.